In contrast, ST2 cells did not secrete MMP-2 or MMP-3, and their interactions with inflammatory cells were weaker than those of ASCs, suggesting that secretions of various MMPs and chemokines and stimulation of inflammatory cells may complicate the use of ASCs for the treatment of rheumatoid arthritis or osteoarthritis. The gene discussed is MMP3; the disease is rheumatoid arthritis.